Press

EBS also reports Series “B” cash infusion of $3.9 million (€3,0 million) from existing investors to commence immediate European commercialization of  NEXT WAVE™ . “Our strategy is to roll-out our NEXT WAVE™ device in a limited manner to key opinion leaders in Europe who treat neurological disorders. Clinical data has demonstrated that NEXT WAVE™ therapy is designed to restore function of deficits in vision caused by stroke, brain trauma, or other neurologic disorders.” Ulf P

With a promising concept uberMetrics Technologies (www.ubermetrics-technologies.com), a spin-off from the Humboldt University Berlin, secured a seven-figure investment from the Klingel Group and the High-Tech Gründerfonds. The Berlin-based startup won the investors over with, among other things, an in-depth analysis of the communication channels of Klingel Group and its subsidiaries. "The media monitoring market is growing – we recognized  this and decided to enter this market segment tog

HQ plus developed competition monitoring tool and closes its first round of financing with the High-Tech Gruenderfonds. The tool helps the hotel owners to adjust their room rates based on price changes in the local competition and market anomalies. HQ plus GmbH is on road to success with its web-based competition monitoring solution (www.hqplus.eu). HQ plus shows the hotel owner at a glance how his room rates are compared to his competitors for the next 365 days. Its customers includes inter

VERSUS IO, the world’s most sophisticated product comparison platform, today announced it has completed its Series A funding round led by Earlybird Venture Capital. VERSUS IO enables users to compare consumer technology products like smartphones and tablets, cities and more. Using VERSUS IO, consumers are able to view results in a simple and clear format, without ‘information overload’ and ultimately allowing consumers to digest complex product data quickly and efficiently. VERSUS IO uses

Dolosys GmbH, a young spin-off of the Charité Department of Anaesthesiology and Intensive Care Medicine, receives financing from High-Tech Gründerfonds (HTGF) and m2f investment Ltd. The Berlin start-up has developed a pain monitor, which can optimize pain therapy for sedated intensive care patients and patients with chronic pain. Dolosys GmbH is going to use the seed investment to complete the development of the pain monitor and to market it after its successful certification as a medical dev

Compositence GmbH, specializing in solutions for cost-effective serial production using carbon and glass fibers, has acquired an increase in capital. The company has gained Zukunftsfonds Heilbronn as a new lead investor; the holding company Mittelständische Beteiligungsgesellschaft Baden-Württemberg (MGB) and venture capitalist High-Tech Gründerfonds are contributing further capital. The innovation of Compositence is a production process with which components made of high-performance fiber

Pylba Inc, an international technology company that develops services for mobile news, today announced that it has secured a $1.7 million investment from High-Tech Gruenderfonds (HTGF), a Germany-based venture capital company, and several strategic investors and business angels. Pylba offers a Mobile Media Publishing Platform (M2P2) that enables publishers to deliver their content to mobile users through an elegant and intuitive app, named Simply. Through Simply, mobile users can very effi

The positive development of the GME German Medical Engineering GmbH, based in Erlangen, convinced the BayBG to enter as a new investor in the medical technology company. Seed investors Bayern Kapital, HTGF and private investors have increased their commitment. This includes, among others, Dr. Dieter Manstein, (co-) inventor of two fundamental methods of modern dermatology. The total volume of financing (Series A) amounted to EUR 1 million. Medical devices based on laser and light systems are

Personal MedSystems GmbH, with locations in Berlin and Frankfurt am Main, develops products and services for mobile healthcare. The Company is receiving growth financing in the amount of 2.5 million EUR from the French investor Seventure Partners. The capital will be used for the further development and market introduction of the company’s products. Myocardial infarction patients with recurring angina pectoris or cardiac arrhythmia often face the question of whether or not they need to call

Rodos BioTarget GmbH (RBT) is pleased to announce that it has in 2012 successfully realized corporate investment actions in the amount of EUR 2.6 million, with additional option payments attached to its milestones for 2013. Institutional investors participating in this round include the InvestImpuls-Fonds of the region of Hannover (Germany) under the management of EnjoyVenture, the High-Tech Gründerfonds and the KfW’s ERP Start Fund. In addition to institutional investors, RBT was able to att

SIRION Biotech GmbH closes new financing round with additional investors SIRION Biotech GmbH has won two additional private investors, one of them being Aumenta GmbH. Both contribute to a large extent to the current financing round side by side with the existing investors Creathor Venture, HTGF, Bayernkapital and KfW, next to the Managing Directors. The new funds will further strengthen access to the Japan and USA markets and drive the evaluation of clinical programs for viral vectors and com

Milestone Venture Capital invests double-digit millions in international expansion and continued growth of nfon AG nfon AG, a provider of outsourced cloud phone systems (IP-Centrex) and all associated services, is receiving growth financing in the double digit millions from Milestone Venture Capital GmbH (MVC) in Hösbach. The capital will be used for globalization plans as well as continued growth, particularly in the large customer segment. Both partners are reacting to the increasing de

Trend market Online donations: Growth capital for Altruja to its third anniversary Social Fundraising made easy! That is already the slogan and mission of Nicolas Reis, Andreas Jagdhuber und Stefan Grothkopp for three years now. In March 2010 the three entrepreneurs founded Altruja GmbH. With new growth capital Altruja widens its business activities and expands to the international donation markets. The company supports with their innovative online-fundraising tools non-profit organizations, po

Clinical Trials for the TRINITY transcatheter aortic valve to begin this year Transcatheter Technologies GmbH, the transcatheter heart valve company that is developing the TRINITY fully repositionable device for transcatheter aortic valve implantation, announced today that it has closed its € 2.6 million 'Series B' funding round. Existing investors and undisclosed new investors participated in this funding round, which will be used to enter clinical trials. Rolf Käse, PhD, lead investor

CryoTherapeutics GmbH (CryoTherapeutics), the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, announced today that it has completed a second closing of its Series A financing round, with Peppermint VenturePartners (PVP) via its new Charité Biomedical Fund joining the investor consortium. The additional investment by PVP is in addition to the Series A financing round closed in June 2012 by NRW.BANK, High-Tech Gründerfonds (HTGF), private invest

A consortium of investors centered around the Swiss holding company b-to-v Partners AG has invested in the young Regensburg-based software company ondeso along with previous investors Bayern Kapital GmbH and High-Tech Gründerfonds. Founded in mid-2010, ondeso GmbH has specialized in developing products having to do with IT security for manufacturing, production, and infrastructure companies (“Industrial IT Security”) and has already acquired well-known companies as clients, such as automoti